Abstract

Antiretroviral drugs (ARVs) requires adherence of more than 95% for adequate viral suppression. The consequences of poor adherence are failure of viral suppression, decrease CD4 cell count, disease progression, drug resistance, risk of transmission of resistance virus and limited future treatment options. Published data on adherence to ARVs in Kenyan adolescents is limited. The purpose of this study was to determine the ARVS adherence level and describe the healthcare system, medication and social environmental factors affecting this adherence among Human Immune-deficiency Virus (HIV) positive adolescents. This was a descriptive cross-sectional study, where 185 patients aged 10-18 years who had been on ARVs for at least two years were systematically and randomly selected. Only 129 respondents who were HIV fully disclosed were interviewed using a structured questionnaire about their experience taking ARVs. Adherence was measured based on a composite score derived from a three questions adherence tool developed by Center for Adherence Support Evaluation (CASE). Data was also collected via Focused Group Discussion, Key Informant Interviews and from records retrieval. Data analysis was done using Epi data software 3.1 with statistical significance set at p<0.05. Overall, 185 patients were selected but 129 disclosed patients were interviewed; 52.7% males and 47.3% females, estimated level of adherence of 67.34% and the main (63.6%) reason for missing therapy was forgetting. Long waiting time in the clinic and stigmatization were other factors found to affect adherence. The CASE Index Tool depicted high reliability with a Cronbach’s α=0.696. The results showed a significant positive correlation between CD4 counts and adherence (Rh0=0.255, p=0.003) and a significant inverse correlation between Viral Load levels and Adherence (Rh0= -0.189, p=0.031). Therefore, the 67.34% adherence level to ART reported in this study is below optimum adherence of 95%. This study gives the following recommendations; (a) Policy review on HIV disclosure procedures with training of health workers on it (b) Put fitting strategies to improve patients’ ability to impact on forgetfulness (c) Clinic staff to adopt the use of CASE Tool in assessing adolescent’s adherence to ARVs.

Highlights

  • Children who acquired Human Immune-deficiency Virus (HIV) from their mothers comprise two groups of HIV infected adolescents who are living longer, healthier lives as a result of increased access to antiretroviral therapy; those who acquired HIV throughWambugu Naomi et al.: Determinants of Adherence to Antiretroviral Among HIV Positive Adolescents at Comprehensive Care Clinic, Gertrude’s Children Hospital, Nairobi, Kenya vertical transmission and those who acquired HIV through horizontal transmission

  • It is estimated that 10.3 million youth aged 15-24 years are living with HIV/Acquired Immune-Deficiency Syndrome, AIDS and half of all new infections are occurring among young people on a global basis [49]

  • Sub-Saharan Africa accounts for almost 67% of all people living with HIV/AIDS [48] and yet only a handful of studies in the region have investigated outcomes on ART in the emerging group of HIV infected adolescents [4] sexually active contributed to increased rate of new HIV infections to their sexual partners; young people aged 15–24 years accounted for 42% of new HIV infections in people aged 15 years and older; yet nearly 80% (4 million) of this YPLWHIV live in sub-Saharan Africa with Kenya being among the countries contributing to the highest burden [42]

Read more

Summary

Introduction

Children who acquired HIV from their mothers comprise two groups of HIV infected adolescents who are living longer, healthier lives as a result of increased access to antiretroviral therapy; those who acquired HIV throughWambugu Naomi et al.: Determinants of Adherence to Antiretroviral Among HIV Positive Adolescents at Comprehensive Care Clinic, Gertrude’s Children Hospital, Nairobi, Kenya vertical transmission and those who acquired HIV through horizontal transmission (largely sexual). Children who acquired HIV from their mothers comprise two groups of HIV infected adolescents who are living longer, healthier lives as a result of increased access to antiretroviral therapy; those who acquired HIV through. It is estimated that 10.3 million youth aged 15-24 years are living with HIV/Acquired Immune-Deficiency Syndrome, AIDS (most without knowing that they are infected) and half of all new infections are occurring among young people on a global basis [49]. Between the age groups 15-19 years and 20-24 years, HIV prevalence among women nearly doubles, from 4% to 7% [31]. The question to ponder about this is, “What will be the implication of this statistics for a HIV infected generation ”?

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call